Checchi Capital Advisers, LLC Prothena Corp Public LTD CO Transaction History

Checchi Capital Advisers, LLC

  • $1.78 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 01, 2018
SELL
$27.95 - $45.04 $266,307 - $429,141
-9,528 Closed
0 $0
Q4 2017

Feb 02, 2018
SELL
$35.44 - $63.76 $70,880 - $127,520
-2,000 Reduced 17.35%
9,528 $357,000
Q3 2017

Nov 02, 2017
BUY
$53.83 - $67.75 $620,552 - $781,022
11,528
11,528 $747,000

Others Institutions Holding PRTA

# of Institutions
184
Shares Held
42.7M
Call Options Held
162K
Put Options Held
102K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $678M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Checchi Capital Advisers, LLC Portfolio

Follow Checchi Capital Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Checchi Capital Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Checchi Capital Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email